Hypoglycemia is defined by a low blood glucose level associated to clinical symptoms. Hypoglycemia may be related to treatment of diabetes, but also to drugs, alcohol, critical illness, cortisol insufficiency including hypopituitarism, insulinoma, bariatric or gastric surgery, pancreas transplantation or glucagon deficiency, or may be surreptitious. Some hypoglycemic episodes remain unexplained, and genetic, paraneoplastic and immune causes should be considered. Genetic causes may be related to endogenous hyperinsulinism and to inborn errors of metabolism (IEM). Endogenous hyperinsulinism is related to monogenic congenital hyperinsulinism, and especially to mutations of the glucokinase-activating gene or of insulin receptors, both characterised by postprandial hypoglycemia with major hyperinsulinism. In adulthood, IEM-related hypoglycemia can persist in a previously diagnosed childhood disease or may be a presenting sign. It is suggested by systemic involvement (rhabdomyolysis after fasting or exercising, heart disease, hepatomegaly), sometimes associated to a family history of hypoglycemia. The timing of hypoglycemic episodes with respect to the last meal also helps to orientate diagnosis. Fasting hypoglycemia may be related to type 0, I or III glycogen synthesis disorder, fatty acid oxidation or gluconeogenesis disorder. Postprandial hypoglycemia may be related to inherited fructose intolerance. Exercise-induced hyperinsulinism is mainly related to activating mutation of the SLC16A1 gene. Besides exceptional ectopic insulin secretion, paraneoplastic causes involve NICTH (Non-Islet-Cell Tumour Hypoglycemia), caused by Big-IGF2 secretion by a large tumour, with low blood levels of insulin, C-peptide and IGF1. Autoimmune causes involve antibodies against insulin (HIRATA syndrome), especially in case of Graves' disease, or against the insulin receptor. Medical history, timing, and insulin level orientate the diagnosis.
Keywords: Anti-insulin receptor and insulin antibodies; Beta-oxidation disorders; Erreur métabolique innée; Glucokinase mutation; Glycogen synthesis disorder; HIRATA syndrome; Hereditary fructose intolerance; Hypoglycemia; Hypoglycémie; IGF2; Inborn errors of metabolism; Insulin receptor mutation; Insulinorésistance de type B; Intolérance héréditaire au fructose; Mutation de la glucokinase; Mutation du récepteur de l’insuline; NICTH; Neoglucogenesis disorders; Récepteur anti-insuline et anticorps anti-insuline; Syndrome HIRATA; Trouble de la synthèse du glycogène; Troubles de la beta-oxydation; Troubles de la néoglucogenèse; Type B insulin resistance.
Copyright © 2020. Published by Elsevier Masson SAS.